Bullboard - Stock Discussion Forum Trevena Inc TRVN

Healthcare Biotechnology

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of medicines for patients with central nervous system (CNS) disorders. The Company has one approved product in the United States, OLINVYK (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative... see more

Add To Watchlist

OTCPK:TRVN - Post Discussion

Trevena Inc > FDA site

View:

Post by SandMan67 on Aug 08, 2020 5:38am

FDA site

On FDA site as well as 'popular news' sites. Trevena will do a press release Monday (hopefully before open) and the stock should respond for a nice gain. They will also publish qtrly earnings this week. I have a concern they will announce shares being issued to support this new business which could cause a slight dip later in the week but looks like a great long term hold (very good odds they are bought out by big pharma - Pfizer?).
https://www.fda.gov/news-events/press-announcements/fda-approves-new-opioid-intravenous-use-hospitals-other-controlled-clinical-settings

370